CD8A and neoplasm: Because of the CD8α administration before day 9 in the P1C4+ Cion + CD8α group, the unirradiated tumor volume in the P1C4 + Cion + CD8α group was 1.7-fold greater than that in the Comb group at the initiation of the treatment on day 9.